These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25345987)

  • 41. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N; Rocha RS
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):310-4. PubMed ID: 6762634
    [No Abstract]   [Full Text] [Related]  

  • 42. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of repeated praziquantel treatment on schistosomiasis mekongi morbidity as detected by ultrasonography.
    Chigusa Y; Ohmae H; Otake H; Keang H; Sinuon M; Saem C; Socheat D; Matsuda H
    Parasitol Int; 2006 Dec; 55(4):261-5. PubMed ID: 16893676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 45. Humoral and cellular immune response in schistosomiasis pre and post praziquantel therapy.
    Hamadto HH; Rashed SM; el Said A; Elhayawan IA
    J Egypt Soc Parasitol; 1990 Dec; 20(2):667-72. PubMed ID: 2230324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of refractory schistosomiasis.
    Hipgrave DB
    Med J Aust; 1997 May; 166(10):567; author reply 568. PubMed ID: 9196496
    [No Abstract]   [Full Text] [Related]  

  • 47. Praziquantel in the treatment of bilharzia.
    Ward JM
    Cent Afr J Med; 1983 Nov; 29(11):227-9. PubMed ID: 6671208
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of oxamniquine and praziquantel on intrasplenic pressure and portal vein diameter in hepatosplenic schistosomiasis.
    Massoud AM; Ghoneem M; Massoud M
    J Egypt Soc Parasitol; 1986 Dec; 16(2):427-37. PubMed ID: 3782898
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
    Coutinho A; Domingues AL; Neves J; Almeida ST
    Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic effect of BILT combined with praziquantel in treatment of chronic schistosomiasis].
    Ru-Yi L; Na Z; Ni-Na P; Li-le L; Yu H; Yan M; Hong-Bo W
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 May; 29(5):648-650. PubMed ID: 29469371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intestinal schistosomiasis, importation of a neglected tropical disease in Romania. Case report of a traveler to endemic regions.
    Neghina R; Neghina AM; Merkler C; Marincu I; Moldovan R; Iacobiciu I
    Travel Med Infect Dis; 2009 Jan; 7(1):49-51. PubMed ID: 19174302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of repeated application of praziquantel in treatment of hepatic fibrosis due to schistosomiasis].
    Hong-Bao L; Ming S
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Oct; 29(2):241-242. PubMed ID: 29469337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematospermia due to schistosome infection in travelers: diagnostic and treatment challenges.
    Schwartz E; Pick N; Shazberg G; Potasman I
    Clin Infect Dis; 2002 Dec; 35(11):1420-4. PubMed ID: 12439807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Compliance of film-coated praziquantel tablets in schistosomiasis transmission-controlled areas].
    Cao CL; Bao ZP; Chen L; Wang DH; Meng XH; Wang L; Zhang YY; Wang H; Zhong B; Zhao GM; Guo JG
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):659-63. PubMed ID: 22379821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sociocultural aspects of mass delivery of praziquantel in schistosomiasis control: the Abeokuta experience.
    Adeneye AK; Akinwale OP; Idowu ET; Adewale B; Manafa OU; Sulyman MA; Omotola BD; Akande DO; Mafe MA; Appelt B
    Res Social Adm Pharm; 2007 Jun; 3(2):183-98. PubMed ID: 17561219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical study on hepatosplenomegalic schistosomiasis japonica on Leyte Island: follow-up study 4 years after treatment with praziquantel.
    Hayashi M; Matsuda H; Tormis LC; Noseñas JS; Blas BL
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):498-501. PubMed ID: 6535265
    [No Abstract]   [Full Text] [Related]  

  • 58. Developing novel strategies to prevent parasitic infections.
    Staines HM; Croft SL; Horrocks PD
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):783-5. PubMed ID: 21810050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Praziquantel--a new antiparasitic drug.
    Med Lett Drugs Ther; 1982 Dec; 24(624):108-9. PubMed ID: 6755206
    [No Abstract]   [Full Text] [Related]  

  • 60. Further experience with praziquantel in schistosoma japonicum infections.
    Fu FY; Zheng JS; Chen WQ; Qin KS; Jin MY; Liu X; Wang QL; Lu SC
    Chin Med J (Engl); 1984 Jan; 97(1):47-52. PubMed ID: 6428832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.